Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis.

Literature DB >> 31945348

Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis.

Silke Frey¹, Heinrich Sticht², Dagmar Wilsmann-Theis³, Anne Gerschütz⁴, Katharina Wolf⁵, Sabine Löhr⁴, Stefan Haskamp⁴, Benjamin Frey⁶, Madelaine Hahn¹, Arif B Ekici⁴, Steffen Uebe⁴, Christian Thiel⁴, André Reis⁴, Harald Burkhardt⁷, Frank Behrens⁷, Michaela Köhm⁷, Jürgen Rech¹, Georg Schett¹, Gunter Assmann⁸, Külli Kingo⁹, Sulev Kõks¹⁰, Rotraut Mössner¹¹, Jörg C Prinz¹², Vinzenz Oji¹³, Peter Schulz¹⁴, Luis E Muñoz¹, Andreas E Kremer⁵, Jörg Wenzel³, Ulrike Hüffmeier¹⁵.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2020 PMID： 31945348 DOI： 10.1016/j.jid.2019.11.024

Source DB: PubMed Journal: J Invest Dermatol ISSN： 0022-202X Impact factor: 8.551

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments.

Authors: Mariko Seishima; Kento Fujii; Yoko Mizutani
Journal: Am J Clin Dermatol Date: 2022-06-15 Impact factor: 6.233

Review 2. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors: Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal: J Invest Dermatol Date: 2021-07-22 Impact factor: 8.551

Review 3. Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease.

Authors: Helena Iznardo; Lluís Puig
Journal: Int J Mol Sci Date: 2021-04-21 Impact factor: 5.923

4. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.

Authors: Siew Eng Choon; Mark G Lebwohl; Slaheddine Marrakchi; A David Burden; Tsen-Fang Tsai; Akimichi Morita; Alexander A Navarini; Min Zheng; Jinhua Xu; Hamida Turki; Sushmita Rajeswari; Hongjie Deng; Kay Tetzlaff; Christian Thoma; Hervé Bachelez
Journal: BMJ Open Date: 2021-03-30 Impact factor: 2.692

Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis.

Review 1. Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments.

Review 2. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Review 3. Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease.

4. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.

Review 5. "Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis.

Review 6. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin.

Review 7. Diagnosis of Generalized Pustular Psoriasis.

Review 8. Pathophysiology of Generalized Pustular Psoriasis.

Review 9. Neutrophil Extracellular Traps in Skin Diseases.

Review 10. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis.